Hainan Haiyao Co., Ltd. (SZSE: 000566)
Health Care · Pharmaceuticals · CN
CN¥4.84
-11.19% today · -21.9% 1Y
Hainan Haiyao Co., Ltd. (SZSE: 000566) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $934.08M and employs 1,738 people.
Over the last twelve months the share price has lost 21.9%, trading between 3.56 and 9.24.
Tweenvest scores Hainan Haiyao Co., Ltd. across four factors: quality 38/100, value 48/100, growth 0/100. Its strongest factor is value.
000566 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $934.08M
- Revenue (TTM)
- $114.94M
- P/E
- —
- EPS
- -0.34
- Dividend yield
- —
- Beta (5Y)
- 0.07
- 52-week high
- CN¥9.24
- 52-week low
- CN¥3.56
- Avg volume (3M)
- —
- Shares outstanding
- 1.30B
- Employees
- 1,738
- Next earnings
- —
About Hainan Haiyao Co., Ltd.
Hainan Haiyao Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices. Its products include cephalosporin series, gastrointestinal series, oncology series, cochlear implant series, active pharmaceutical ingredient (API) series, and intermediate series. The company was founded in 1965 and is headquartered in Haikou, China.
- ISIN
- CNE0000004W8
- Founded
- 1965
- Listed since
- May 25, 1994
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.